Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes

Postprandial hyperglycemia in type 2 diabetes is characterized by impaired insulin secretion and action, decreased glucose effectiveness and defective suppression of glucagon secretion. Newly available therapies for type 2 diabetes target the pathway of the incretin hormone glucagon-like peptide-1 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Smushkin, Galina, Vella, Adrian
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048000/
https://www.ncbi.nlm.nih.gov/pubmed/21437121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048000/
https://www.ncbi.nlm.nih.gov/pubmed/21437121

Ejemplares similares